These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 6265228

  • 1. Relation between brain catecholamine receptors and dopaminergic stereotypy in rat strains.
    Helmeste DM, Seeman P, Coscina DV.
    Eur J Pharmacol; 1981 Feb 19; 69(4):465-70. PubMed ID: 6265228
    [Abstract] [Full Text] [Related]

  • 2. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S, Rupniak NM, Hall MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2921-7. PubMed ID: 6138043
    [Abstract] [Full Text] [Related]

  • 3. Dopamine D2 receptors and dopamine metabolism. Relationship between biochemical and behavioural effects of substituted benzamide drugs.
    Magnusson O, Fowler CJ, Köhler C, Ogren SO.
    Neuropharmacology; 1986 Feb 01; 25(2):187-97. PubMed ID: 2939362
    [Abstract] [Full Text] [Related]

  • 4. Spontaneous and apomorphine-induced locomotor changes parallel dopamine receptor differences in two rat strains.
    Helmeste DM.
    Pharmacol Biochem Behav; 1983 Jul 01; 19(1):153-5. PubMed ID: 6622508
    [Abstract] [Full Text] [Related]

  • 5. Lidocaine kindling is accompanied by an increase in apomorphine stereotypy and mesolimbic dopamine D2 receptor density.
    Csernansky JG, Csernansky CA, Glick SA, Hollister LE.
    Psychopharmacol Bull; 1985 Jul 01; 21(3):707-11. PubMed ID: 2930865
    [No Abstract] [Full Text] [Related]

  • 6. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J.
    Eur J Pharmacol; 1985 Jul 11; 113(1):79-88. PubMed ID: 2931283
    [Abstract] [Full Text] [Related]

  • 7. D1 and D2 dopamine binding site up-regulation and apomorphine-induced stereotypy.
    Chipkin RE, McQuade RD, Iorio LC.
    Pharmacol Biochem Behav; 1987 Dec 11; 28(4):477-82. PubMed ID: 2893388
    [Abstract] [Full Text] [Related]

  • 8. Thioridazine chronic administration: a behavioural and autoradiographic study.
    Calzà L, Giardino L, Piazza PV, Amato G.
    Neurosci Lett; 1990 Feb 05; 109(1-2):206-11. PubMed ID: 2314636
    [Abstract] [Full Text] [Related]

  • 9. Prolonged inhibition of striatal dopamine receptor sites by isofloxythepin.
    Lau YS, Runice C.
    Eur J Pharmacol; 1985 Oct 08; 116(1-2):25-31. PubMed ID: 2865162
    [Abstract] [Full Text] [Related]

  • 10. Enhanced stereotypic behavior by chronic treatment with bromocriptine accompanies increase of D-1 receptor binding.
    Le WD, Zhou XD, Jin GZ.
    Life Sci; 1988 Oct 08; 42(19):1841-5. PubMed ID: 2966885
    [Abstract] [Full Text] [Related]

  • 11. Dissociation between behavioral effects of (-)-N-(2-chloroethyl)-norapomorphine and D2 dopamine receptor-like activity.
    Helmeste DM.
    Eur J Pharmacol; 1983 Nov 25; 95(3-4):277-81. PubMed ID: 6317413
    [Abstract] [Full Text] [Related]

  • 12. Modification of apomorphine-induced behaviour following chronic swim exercise in rats.
    Dey S, Singh RH.
    Neuroreport; 1992 Jun 25; 3(6):497-500. PubMed ID: 1391756
    [Abstract] [Full Text] [Related]

  • 13. Chronic clorgyline and pargyline increase apomorphine-induced stereotypy in the rat.
    Campbell IC, Durcan MJ, Cohen RM, Pickar D, Chugani D, Murphy DL.
    Pharmacol Biochem Behav; 1985 Dec 25; 23(6):921-5. PubMed ID: 4080777
    [Abstract] [Full Text] [Related]

  • 14. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.
    Hinzen D, Hornykiewicz O, Kobinger W, Pichler L, Pifl C, Schingnitz G.
    Eur J Pharmacol; 1986 Nov 12; 131(1):75-86. PubMed ID: 3816949
    [Abstract] [Full Text] [Related]

  • 15. Mesolimbic dopaminergic supersensitivity following electrical kindling of the amygdala.
    Csernansky JG, Mellentin J, Beauclair L, Lombrozo L.
    Biol Psychiatry; 1988 Feb 01; 23(3):285-94. PubMed ID: 2962647
    [Abstract] [Full Text] [Related]

  • 16. Effect of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea pigs.
    Feigenbaum J, Yanai J, Moon B, Klawans H.
    Neuropharmacology; 1983 Dec 01; 22(12A):1369-76. PubMed ID: 6686653
    [Abstract] [Full Text] [Related]

  • 17. On the mechanism of potentiation of apomorphine-induced stereotypy due to electroconvulsive shock.
    Gulati A, Srimal RC, Dhawan KN, Dhawan BN.
    Neuropharmacology; 1987 Dec 01; 26(12):1733-7. PubMed ID: 3437939
    [Abstract] [Full Text] [Related]

  • 18. Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats.
    Murugaiah K, Theodorou A, Clow A, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1985 Dec 01; 86(1-2):228-32. PubMed ID: 3927361
    [Abstract] [Full Text] [Related]

  • 19. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
    Fujita N, Nakahiro M, Fukuchi I, Saito K, Yoshida H.
    Brain Res; 1985 May 06; 333(2):231-6. PubMed ID: 3158374
    [Abstract] [Full Text] [Related]

  • 20. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S, Kelly E, Davis A, Fleminger S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1985 May 15; 34(10):1665-9. PubMed ID: 2988552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.